Back Back
Cell No. : Cell Name
RCB1465 : SHIP^(-) DT40  update : 2024/01/17
CommentSHIP deficient DT40 cells
Comment from the depositor
Terms and conditionsThere is no restriction regarding use for basic researches. In relation to commercial use and use for patent filing, first of all please contact the RIKEN BRC.
Order Form Order Form(C-0005.pdf)   MTA(C-0007.pdf)   MTA(C-0007p.pdf)  
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (
Basic information Depositor Kurosaki, Tomohiro
Originator Kurosaki, Tomohiro
Year of deposit 1998
Another name H7-11
Original cell DT40
Animal _avian < Birds
Tissue B cell
Classification mutant
Recombinant recombinant
Lifespan infinite
Morphology lymphocyte-like
Cellosaurus(Expasy) CVCL_2G93
deposit info
lot info
Medium Medium List
Culture type Suspension cells
Culture method 浮遊細胞の培養に関する一般的な注意(Japanese)
Culture medium RPMI1640 (4mM Glutamine) + 10% FBS + 1% Chicken serum + 50μM 2-Mercaptoethanol
Antibiotics Free
Passage method dilution
Culture information Passage cell No 1.5-2 x 10 5 cells/ml
Passage ratio 1 : 20 split
SC frequency Subculture : every 2 days
Temperature 39.5 ℃
CO2 concentration 5 %
Freeze medium 90% FBS + 10% DMSO
Freezing method Slow freezing
Mycoplasma (-)
Animal PCR OK
Others Freezing : 1.0-1.5x10 7 cells/ml/vial. Thawing : 1ml of cells into 20ml media. It is unnecessary to remove DMSO. Pass the next day.
Reference information Reference 3
User's Publication 2

To topTop
2336  Maeda A, Kurosaki M, Ono M, Takai T, Kurosaki T.  Requirement of SH2-containing protein tyrosine phosphatases SHP-1 and SHP-2 for paired immunoglobulin-like receptor B (PIR-B)-mediated inhibitory signal.  J Exp Med  1998  187(8):1355-60  PubMed ID: 9547347   DOI: 10.1084/jem.187.8.1355
2280  Ono 1, Okada H, Bolland S, Yanagi S, Kurosaki T, Ravetch JV.  Deletion of SHIP or SHP-1 reveals two distinct pathways for inhibitory signaling.  Cell  1997  90(2):293-301  PubMed ID: 9244303   DOI: 10.1016/s0092-8674(00)80337-2
2284  Takata M, Sabe H, Hata A, Inazu T, Homma Y, Nukada T, Yamamura H, Kurosaki T.  Tyrosine kinases Lyn and Syk regulate B cell receptor-coupled Ca2+ mobilization through distinct pathways.  EMBO J  1994  13(6):1341-9  PubMed ID: 8137818   DOI: 10.1002/j.1460-2075.1994.tb06387.x

To topTop
User's Publication
8598  Suzuki J, Yamaguchi K, Kajikawa M, Ichiyanagi K, Adachi N, Koyama H, Takeda S, Okada N.  Genetic evidence that the non-homologous end-joining repair pathway is involved in LINE retrotransposition.  PLoS Genet.  2009  5:e1000461  PubMed ID: 19390601   DOI: 10.1371/journal.pgen.1000461
16949  Henshall TL, Jones KL, Wilkinson R, Jackson DE.  Src homology 2 domain-containing protein-tyrosine phosphatases, SHP-1 and SHP-2, are required for platelet endothelial cell adhesion molecule-1/CD31-mediated inhibitory signaling  J Immunol  2001  166(5):3098-106  PubMed ID: 11207261   DOI: 10.4049/jimmunol.166.5.3098

Back Back Return Top Page